Clinical trial

Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC

NCT04648033

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-12-07

PhasePHASE1

Study timeline

Study start (actual)2020-12-07Date precision: day

Registry last updated2026-01-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Locally Advanced Non-Small Cell Lung Cancerunresolved

Interventions

Atovaquone Oral SuspensionDRUG · verified · RxNorm: atovaquone Oral Suspension

Standard of care chemotherapyDRUG

Standard of care radiotherapyRADIATION

Sponsors & collaborators

University of Oxfordlead sponsor

Cancer Research UKcollaborator

National Institute for Health Research, United Kingdomcollaborator

NHS Lothiancollaborator

Oxford University Hospitals NHS Trustcollaborator

NHS Research Scotlandcollaborator

Guy's and St Thomas' NHS Foundation Trustcollaborator

Mapped research locations

LondonUnited Kingdom1 EdinburghUnited Kingdom1 OxfordUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04648033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.